Cargando…
Long-Term Follow-Up Result of Hydroxyurea Chemotherapy for Recurrent Meningiomas
OBJECTIVE: Meningiomas represent 18-20% of all intracranial tumors and have a 20-50% 10-year recurrence rate, despite aggressive surgery and irradiation. Hydroxyurea, an inhibitor of ribonucleotide reductase, is known to inhibit meningioma cells by induction of apoptosis. We report the long-term fol...
Autores principales: | Kim, Min-Su, Yu, Dong-Woo, Jung, Young-Jin, Kim, Sang Woo, Chang, Chul-Hoon, Kim, Oh-Lyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Neurosurgical Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550418/ https://www.ncbi.nlm.nih.gov/pubmed/23346322 http://dx.doi.org/10.3340/jkns.2012.52.6.517 |
Ejemplares similares
-
The Clinical Outcome of Hydroxyurea Chemotherapy after Incomplete Resection of Atypical Meningiomas
por: Kim, Jungook, et al.
Publicado: (2017) -
Imatinib Mesylate plus Hydroxyurea Chemotherapy for Cerebellar Meningioma in
a Belgian Malinois Dog
por: JUNG, Hae-Won, et al.
Publicado: (2014) -
Case Report: Long-Term Chemotherapy With Hydroxyurea and Prednisolone in a Cat With a Meningioma: Correlation of FDG Uptake and Tumor Grade Assessed by Histopathology and Expression of Ki-67 and p53
por: Yun, Taesik, et al.
Publicado: (2021) -
A Case of Recurrent Anaplastic Meningioma of the Skull Base with Radiologic Response to Hydroxyurea
por: Gurberg, Joshua, et al.
Publicado: (2014) -
Long-Term Results of Gamma Knife Radiosurgery for Intracranial Meningioma
por: Jang, Chang Ki, et al.
Publicado: (2015)